Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice

被引:59
作者
Silha, JV
Mishra, S
Rosen, CJ
Beamer, WG
Turner, RT
Powell, DR
Murphy, LJ
机构
[1] Univ Manitoba, Dept Internal Med, John Buhler Res Ctr, Winnipeg, MB R3E 3P4, Canada
[2] Univ Manitoba, Dept Physiol, John Buhler Res Ctr, Winnipeg, MB R3E 3P4, Canada
[3] St Joseph Hosp, Maine Ctr Osteoporosis Res & Educ, Bangor, ME USA
[4] Jackson Lab, Bar Harbor, ME 04609 USA
[5] Mayo Clin, Dept Orthoped, Rochester, MN USA
[6] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
关键词
insulin-like growth binding protein-3; osteoblast; osteoclast; transgenic mice;
D O I
10.1359/jbmr.2003.18.10.1834
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IGF-I and their binding proteins are important in bone health. Examination of BMD, osteoblast proliferation, and markers of bone resorption in transgenic mice that constitutively overexpress IGFBP-3 indicates that overexpression of IGFBP-3 increases osteoclast number and bone resorption, impairs osteoblast proliferation, and has a significant negative effect on bone formation. Introduction: Low serum insulin-like growth factor I (IGF-I) levels correlate with an increased risk of osteoporotic fractures. Serum IGF-I is largely bound to IGF-binding protein-3 (IGFBP-3), which can inhibit IGF-I action and enhance delivery of IGF-I to tissues. Its role in bone biology is unclear. Methods: Bone mineral density (BMD), osteoblast proliferation, and markers of bone resorption were examined in transgenic (Tg) mice that constitutively overexpressed human IGFBP-3 cDNA driven by either the cytomegalovirus (CMV) or phosphoglycerate kinase (PGK) promoter. Results: Cultured calvarial osteoblasts from Tg mice expressed the transgene and grew more slowly than cells from wild-type (Wt) mice, and the mitogenic response to IGF-I was attenuated in osteoblasts from Tg mice. Total volumetric BMD and cortical BMD, measured in the femur using peripheral quantitative computed tomography (pQCT) were significantly reduced in both Tg mouse strains compared with Wt mice. PGKBP-3 Tg mice showed the most marked reduction in bone density. Osteocalcin levels were similar in Wt and CMVBP-3 Tg mice but were significantly reduced in PGKBP-3 Tg mice. Urinary deoxypyridinoline and osteoclast perimeter, markers of bone resorption, were significantly increased in both Tg mouse strains compared with Wt mice. Using double labeling with tetracycline, we demonstrated that pericortical and endocortical mineral apposition rate was significantly reduced in PGKBP-3 Tg mice compared with Wt mice. Conclusions: These data show that overexpression of IGFBP-3 increases osteoclast number and bone resorption, impairs osteoblast proliferation, and has a significant negative effect on bone formation.
引用
收藏
页码:1834 / 1841
页数:8
相关论文
共 24 条
  • [1] IGF-I AND PAMIDRONATE INCREASE BONE-MINERAL DENSITY IN OVARIECTOMIZED ADULT-RATS
    AMMANN, P
    RIZZOLI, R
    MULLER, K
    SLOSMAN, D
    BONJOUR, JP
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (05): : E770 - E776
  • [2] THE EFFECT OF SYSTEMICALLY ADMINISTERED RHIGF-I/IGFBP-3 COMPLEX ON CORTICAL BONE STRENGTH AND STRUCTURE IN OVARIECTOMIZED RATS
    BAGI, C
    VANDERMEULEN, M
    BROMMAGE, R
    ROSEN, D
    SOMMER, A
    [J]. BONE, 1995, 16 (05) : 559 - 565
  • [3] BAGI CM, 1994, J BONE MINER RES, V9, P1301
  • [4] INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS IN THE HUMAN CIRCULATION - A REVIEW
    BAXTER, RC
    [J]. HORMONE RESEARCH, 1994, 42 (4-5) : 140 - 144
  • [5] Genetic variability in adult bone density among inbred strains of mice
    Beamer, WG
    Donahue, LR
    Rosen, CJ
    Baylink, DJ
    [J]. BONE, 1996, 18 (05) : 397 - 403
  • [6] CHANGES IN IGF-I AND IGF-II EXPRESSION AND SECRETION DURING THE PROLIFERATION AND DIFFERENTIATION OF NORMAL RAT OSTEOBLASTS
    BIRNBAUM, RS
    BOWSHER, RR
    WIREN, KM
    [J]. JOURNAL OF ENDOCRINOLOGY, 1995, 144 (02) : 251 - 259
  • [7] INSULIN-LIKE GROWTH FACTOR-I (IGF-I)-BINDING PROTEIN COMPLEX IS A BETTER MITOGEN THAN FREE IGF-I
    BLUM, WF
    JENNE, EW
    REPPIN, F
    KIETZMANN, K
    RANKE, MB
    BIERICH, JR
    [J]. ENDOCRINOLOGY, 1989, 125 (02) : 766 - 772
  • [8] Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: A double-blind, placebo-controlled pilot study
    Boonen, S
    Rosen, C
    Bouillon, R
    Sommer, A
    McKay, M
    Rosen, D
    Adams, S
    Broos, P
    Lenaerts, J
    Raus, J
    Vanderschueren, D
    Geusens, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) : 1593 - 1599
  • [9] Canalis Ernesto, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P155
  • [10] Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity
    Conover, CA
    Bale, LK
    Durham, SK
    Powell, DR
    [J]. ENDOCRINOLOGY, 2000, 141 (09) : 3098 - 3103